<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Smooth muscle antibodies (SMA) with specificity for actin, were found with a higher frequency in sera from Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> (NPC) patients than in sera from matched controls </plain></SENT>
<SENT sid="1" pm="."><plain>No correlation could be found between SMA and anti-Epstein-Barr virus (EBV) antibody titres </plain></SENT>
<SENT sid="2" pm="."><plain>There was no parallelism, in individual sera, between the finding of SMA and the occurrence of cold lymphocytotoxins, aother antibody activity found with an abnormally high frequency among <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and NPC patients </plain></SENT>
<SENT sid="3" pm="."><plain>The reason why actin, a weak antigen in experimental animals, may become immunogenic in humans remains unexplained </plain></SENT>
</text></document>